Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06229769 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Natural History Study for Patients With Angelman Syndrome

Study acronym: NatHisAngelman
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv5
  2. Notable Enrollment target: 15 to 30
    • Study description revised
    • Site details revised
    v4
  3. Notable Lead sponsor: Centre Hospitalier Régional de la Citadelle to Centre Hospitalier Universitaire de Liege
    • Collaborators expanded, about 7 words
    v3
  4. Notable Primary endpoints: 7 to 11
    • Secondary endpoints: details revised at 2 of 2 entries
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a 9-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 3-year recruitment phase, a 5 year follow-up and a year to analyze the collected data. The investigators plan to include 30 patients with a semi-annual follow-up for 4 years. The investigators will collect relevant retrospective and prospective data using age-standardized scales and questionnaires for functional motor assessments and global developmental assessment.
Trial Details
NCT Number NCT06229769
Lead Sponsor Centre Hospitalier Universitaire de Liege
Collaborators: Centre Hospitalier Régional de la Citadelle, SYSNAV
Conditions
(from sponsor)
Angelman Syndrome
Related terms Angelman Syndrome
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov